Determination of the value of a centralized iodine prevention of the Precarpathian population
DOI:
https://doi.org/10.24959/cphj.15.1342Keywords:
iodine deficiency, iodine medicines, antistrumin, marketing analysis, cost of iodine preventionAbstract
The analysis of registration of H03C group in the State Register of Drugs in Ukraine has revealed that as of 01.01.2014, there were 6 registered drugs for prevention of iodine deficiency, and 2 of them were produced abroad. As of 25.10.2014, there were only 3 drugs at the pharmaceutical market of Ukraine – Antistrumin (Darnitsya, Ukraine) Yodomaryn (Berlin-Chemie, Germany), Iodide (Farmak, Ukraine). The results of monthly monitoring of the average wholesale price show that their values in 2013 did not change significantly. However, in March and April 2014 there was a sharp increase in prices (the average price of the German drug Yodomaryn increased by more than one and half) due to introduction of 7% VAT on medicines, as well as depreciation of the hryvnia’s official exchange rate at the foreign exchange market. The estimated average annual values of liquidity ratios indicate that the price range for such drug as Yodomaryn 200 mcg № 50, Berlin-Chemie, Germany, depending on the suppliers cannot be considered valid and ethical in relation to the solvency of the citizens of Ukraine. To provide the needs of iodine prevention of the population at large at the expense of local budgets in the Ivano-Frankivsk region, 8 million 557 thousand UAH is needed. In the presence of state of local regional budgets deficit it is reasonable to recommend funding for prevention of endemic goiter at least for children under the age of 14 years; therefore, the Ivano-Frankivsk region should be provided by 1,010,238,24 UAH.References
Наказ МОЗ України від 11.10.2013 р. №875 «Про затвердження протоколів провізора (фармацевта)».
Шідловський В.О., Дейкало І.М. Йододефіцитні захворювання: діагностика, лікування, профілактика. – Тернопіль: Укрмедкнига, 2006. – 124 с.
Bürgi H., Supersaxo Z., Selz B. // Acta Endocrinol. – 1990. – №123. – P. 577-590.
Delange F., Dunn J., Glinoer D. Iodine deficiency in Europe. A continuing concern. – New York: Plenum Press, 1993. – P. 456.
Lyn Patrick // Alternative Medicine Rev. – 2008. – №13 (2). – P. 116-127.
Shakhtarin V.V., Tsyb A.F., Stepanenko V.F. // Int. J. Epidemiol. – 2003. – №32. – P. 584-591.
UNICEF Office for Bosnia-Herzergovina. Iodine status of the population of Bosnia-Herzergovina. – Sarajevo, United Nations Children’s Fund. – 2006. – 15 p.
Wolff J. // Medicine. – 2001. – №80. – P. 20-36.
Zamrazil V. // Thyroid. – 2004. – №14. – P. 49-56.
Zimmermann M.B. // Endocrine Rev. – 2009. – Vol. 30 (4). – P. 376-408.
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
